Tiny study aims to unlock mysteries of brain fog after cancer treatment
NCT ID NCT07375628
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study will follow 10 patients getting CAR-T therapy to learn why some develop severe brain inflammation (ICANS). Researchers will use brain scans and cognitive tests before, during, and after treatment. The goal is to better understand the link between brain inflammation and thinking problems, not to test a new drug.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors understand why some patients develop brain inflammation and thinking problems after CAR-T therapy.
- What could go wrong
- This is a very small, early observational study with only 10 participants, so findings may not apply to everyone. It does not test a new treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CAR-T CELL THERAPY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- CAR-T breakthroughs come with infection risks – new study aims to decode them
- Ultra-Fast CAR-T cells aim to beat back tough lymphomas
- Could a simple drug tame the dangerous side effects of CAR-T cancer therapy?
- Could talk therapy boost brain function in schizophrenia?
- CAR-T therapy aimed at tough kidney disease in kids — but trial never started
- Promising CAR-T trial for kids with rare vasculitis pulled before start